INTRODUCTION {#sec1-1}
============

The placement of dental implant is an effective and predictable treatment modality for replacing a missing tooth. Using implant survival as the indicator of successful clinical outcome, a majority of clinical studies have shown very promising results for dental implants. The success of implant therapy has been reported with a favorable high survival rates ranging between 95% and 99%.\[[@ref1]\]

Despite the high success rates and stability of dental implants, failures do occur.\[[@ref2]\] Implant failure can be divided into early (prior to prosthetic treatment) or late (after prosthetic rehabilitation).\[[@ref3]\] Excessive occlusal stress in conjunction with host characteristics and bacterial-induced marginal bone loss (peri-implantitis) seem to be the major etiologic factors for late losses. On the other hand, operator experience, excessive surgical trauma, bacterial contamination, premature overloading with micromotion, and some local as well as systemic characteristics of the host are believed to be the most common causes of implant failure at an early stage after implant placement.\[[@ref4]\]

Most implant failures have been reported in the maxilla, with almost three times as many implant losses as in the mandible.\[[@ref5]\] Early failures have been reported to vary between 1.5% and 21%.\[[@ref3][@ref5]--[@ref8]\] Implants undergoing early failure will show progressive bone loss on radiographs during the early stages of healing (4 to 6 weeks). Clinically, signs of infection such as the presence of fistula in the soft tissue covering the implants, purulent discharge on manipulation, bluish red discoloration of surrounding tissue, and mild discomfort at the implant site may also be present. If left untreated, bone loss will continue and implant failure will result. Early failing implants can be successfully managed by mechanical debridement, antimicrobial therapy, and guided bone regeneration (GBR).\[[@ref9]\]

GBR\[[@ref10][@ref11]\] is a regenerative procedure which is based on the principle of guided tissue regeneration and involves the placement of a barrier membrane to protect the blood clot and create a secluded space around the osseous defect enabling bone regeneration without competition from other tissues. Several barrier membranes and bone grafting materials have been successfully used in different animal and human studies to regenerate the lost bone around the osseointegrated implants.\[[@ref12]\] Most recently, many investigations\[[@ref13]--[@ref15]\] have focused on the use of products derived from type-1 and type-3 porcine or bovine collagen in combination with bone substitute like bioactive glass as filling material in the osseous defects.

A case report has been presented here, wherein an early failing implant was salvaged by GBR technique using bioactive glass (Perioglass^®^) as a defect filling material and resorbable collagen membrane (Haeliguide^®^) as a barrier membrane.

CASE REPORT {#sec1-2}
===========

A 35-year-old female patient was referred to the Department of Periodontology and Implantology, Bapuji Dental College and Hospital, Davangere, Karnataka State, for the implant placement in the upper front tooth region. The tooth was removed 6 months back due to excessive mobility. The patient was systemically healthy and non-smoker.

Clinical examination revealed missing upper right lateral incisor (\#12) with other neighboring teeth in good health and alignment. The patient was maintaining good oral hygiene and showed keen interest in undergoing implant therapy. A written consent form was submitted by her. Necessary investigations like complete hemogram, intra-oral periapical (IOPA) radiograph \[[Figure 1](#F1){ref-type="fig"}\], and computed tomographic (C.T.) scan of the edentulous site were done \[Figures [2](#F2){ref-type="fig"}--[4](#F4){ref-type="fig"}\]).

![Pre-operative intraoral periapical radiograph of the edentulous site](JISP-17-131-g001){#F1}

![Computed tomographic scan showing the labio-palatal width of the available bone at the edentulous site](JISP-17-131-g002){#F2}

![Computed tomographic scan showing the mesio-distal width of the available bone at the edentulous site](JISP-17-131-g003){#F3}

![Computed tomographic scan showing the height of the available bone at the edentulous site](JISP-17-131-g004){#F4}

C.T. scan measurements revealed inadequate bone volume labio-palatally to accommodate a standard-diameter implant \[[Figure 2](#F2){ref-type="fig"}\]. The patient did not accept the suggested treatment modalities to augment the deficient labio-palatal bone due to increased expense and prolonged time for several stages, until tooth reconstruction. Therefore, a decision was taken to place a mini implant. The implant used was TRI-N-SR mini implants (Hi-Tech Implants, Herzlia, Israel). This is a threaded, self-tapping, uncoated titanium alloy implants and is available in 10 mm and 13 mm lengths with a fixed diameter of 2.4 mm. The TRI-N-SR mini implant is a single-piece implant with large grit sand blasted and acid etched surface (SLA) and with a smooth polished collar and abutment surface. According to the measurements obtained with the help of C.T. scan, a 10 mm long implant was selected and placed according to the manufacturer\'s instructions. The insertion torque achieved was only 20 Ncm (indicating less primary stability), and therefore an immediate provisional acrylic restoration was avoided. A decision was made to directly give a final porcelain fused-to-metal (PFM) prosthesis to the patient at the end of 6 weeks, as an early loading protocol. Since it was a one-piece implant, the patient was instructed to follow an appropriate soft diet for 1 week, and avoid putting any kind of excessive load on the implant. The patient reported 10 days after the procedure for the removal of the sutures. The soft tissue healing was satisfactory and there was no clinical mobility of the implant at this time. The patient was now asked to report back at the end of 6 weeks for the fabrication of permanent prosthesis.

When patient returned at the end of 6 weeks, overall periodontal examination revealed fair oral hygiene according to OHI-S index by Green and Vermillion. A periodontal diagnosis of dental plaque-induced gingival disease -- gingivitis associated with dental plaque only without other local contributing factors was arrived at, after thorough clinical examination. However, grade I mobility (according to the Misch\'s Clinical Implant Mobility Scale) was detected with respect to the implant placed. The Misch\'s Clinical Implant Mobility Scale uses two rigid instruments to apply a labio-lingual force of approximately 500 g and grades mobility of implant according to the following scale \[[Table 1](#T1){ref-type="table"}\]. The peri-implant probing depth was 6 mm on the mesial and 5 mm on distal aspect. Bleeding on probing was also positive. Intraoral periapical (IOPA) radiograph revealed bone loss on both mesial and distal aspects of the implant \[Figures [5](#F5){ref-type="fig"} and [6](#F6){ref-type="fig"}\]. A clinical diagnosis of failing implant was made and a decision was taken to salvage the failing implant by means of GBR procedure to regenerate the lost bone.

###### 

Misch\'s clinical implant mobility scale

![](JISP-17-131-g005)

![Six-week photograph of the implant](JISP-17-131-g006){#F5}

![Six-week intraoral periapical radiograph of the implant showing bone loss mesial and distal to the implant](JISP-17-131-g007){#F6}

Antibiotic (amoxicillin 500 mg/potassium clavulanate 125 mg tabs, three times daily) was started a day prior to the surgical procedure. Under antibiotic cover, local anesthesia was given, intra-crevicular incisions were placed, and full-thickness mucoperiosteal flap was reflected. The infected granulation tissue was removed from the defect and the implant surfaces were thoroughly debrided using plastic curettes (Straumann^®^ Dental Implant System, Straumann AG, Basel, Switzerland). A circumferential defect with slight buccal bone loss was evident around the implant \[Figures [7](#F7){ref-type="fig"} and [8](#F8){ref-type="fig"}\]. Next, surface decontamination was done by applying a supersaturated solution of citric acid for 30 s followed by complete rinsing of the site with normal saline \[[Figure 9](#F9){ref-type="fig"}\].

![Circumferential defect around the failing implant](JISP-17-131-g008){#F7}

![Circumferential defect with slight buccal bone loss around the failing implant](JISP-17-131-g009){#F8}

![Decontamination by supersaturated solution of citric acid](JISP-17-131-g010){#F9}

The peri-implant defect was filled with PerioGlas^®^ (NovaBone Products, LLC, Alachua, Florida, USA) starting from the bottom of the defect \[Figures [10](#F10){ref-type="fig"} and [11](#F11){ref-type="fig"}\]. However, the graft material was moistened in sterile saline before placement into the defect. Following grafting, the bio-resorbable type-I bovine collagen membrane (Healiguide^®^, Advanced Biotech Products Pvt. Ltd., Chennai, India) was trimmed and adapted over the entire defect so as to cover 2-3 mm of the surrounding alveolar bone and to ensure stability of the graft material \[Figures [12](#F12){ref-type="fig"} and [13](#F13){ref-type="fig"}\]. Primary wound closure was achieved, using non-resorbable 3-0 black braided silk sutures (Mersilk^®^, Ethicon, Johnson and Johnson, India) and the area was covered with periodontal dressing (Coe-pak, G. C. India) for 7 days \[Figures [14](#F14){ref-type="fig"} and [15](#F15){ref-type="fig"}\]. The patient continued with the antibiotic coverage 1 week postsurgery and was also instructed to rinse twice daily with 0.2% chlorhexidine (Clohex, Dr. Reddy\'s laboratories ltd., India). The dressing and sutures were removed after 7 days. The patient was asked to continue with 0.2% chlorhexidine for 3 weeks and to avoid brushing this region for the same time period. Regular recall was done, once every month for 6 month period.

![PerioGlas^®^ being carried to the peri-implant defect](JISP-17-131-g011){#F10}

![Peri-implant defect filled with PerioGlas^®^](JISP-17-131-g012){#F11}

![Trimmed and shaped resorbable collagen membrane (Healiguide^®^)](JISP-17-131-g013){#F12}

![Resorbable collagen membrane (Healiguide^®^) adapted over the periimplant defect](JISP-17-131-g014){#F13}

![Primary wound closure achieved using non-resorbable 3-0 black braided silk sutures](JISP-17-131-g015){#F14}

![Surgical area covered with periodontal dressing](JISP-17-131-g016){#F15}

At the end of 6 month follow-up, the healing was found to be complete with a clinical evidence of healthy and firm mucosa around the implant \[[Figure 16](#F16){ref-type="fig"}\] and no sign of clinically detectable implant mobility. Intraoral periapical (IOPA) radiograph showed complete resolution of the treated defect, which may be due to regeneration of bone \[[Figure 17](#F17){ref-type="fig"}\].

![Six-month follow-up photograph showing complete healing](JISP-17-131-g017){#F16}

![Intraoral periapical radiograph showing complete regeneration of bone and resolution of the treated defect](JISP-17-131-g018){#F17}

After obtaining satisfactory clinical outcome, the process of fabrication of definitive prosthesis was taken up. The axial surfaces of the implant were modified using multi-fluted carbide burs under copious irrigation. The reduction of the axial surfaces was kept as minimum as possible. As the abutment was modified intraorally, an impression coping and implant analog could not be used. Hence, a direct pick up impression was made using additional silicone material, without the use of any impression coping, and the cast was poured using type-4 dental stone. Shade selection was also done during this appointment, and finally, the definitive porcelain fused-to-metal prosthesis was fabricated in the laboratory and delivered to the patient \[Figures [18](#F18){ref-type="fig"}--[20](#F20){ref-type="fig"}\] with the best satisfaction of the patient.

![Modified axial surface of the implant abutment](JISP-17-131-g019){#F18}

![Pick-up impression of the implant abutment](JISP-17-131-g020){#F19}

![Final porcelain fused to metal prosthesis](JISP-17-131-g021){#F20}

DISCUSSION {#sec1-3}
==========

The clinical evidence of osseointegration revolutionized the field of dentistry and made implant therapy a viable alternative to the earlier treatments of replacing missing teeth. Osseointegrated implants present predictable, reproducible, and durable results. Despite success which ranges from 95% to 99%,\[[@ref1]\] failures do occur.\[[@ref2]\]

Implant failures can be classified as *Biological failures* (related to the biological process), *Mechanical failures* (fracture of implants, connecting screws, bridge frameworks, coatings, etc.), *Iatrogenic failures* (nerve damages, wrong alignment of implants, etc.), and *Inadequate or insufficient patient adaptation* (psychological, aesthetical, and phonetical problems). Biological implant failures can be further classified as *Early failure* (before loading) and *Late failure* (after loading).\[[@ref3]\]

Factors contributing to implant failures can be divided into *Endogenous* (systemic and local) and *Exogenous* (operator-related and biomaterial-related). Proposed etiology for early failure may include inexperienced operator, excessive surgical trauma, bacterial contamination, premature overloading with micromotion during the healing phase, and some local as well as systemic characteristics of the host.\[[@ref4]\]

Due to lower bite forces in the anterior region of mouth,\[[@ref16]\] esthetic demand and support of scientific literature with successful protocol in mini-implants\[[@ref17]--[@ref19]\] a pre-operative decision was made to give immediate provisional acrylic restoration for 4-6 weeks, followed by final porcelain fused to metal (PFM) prosthesis at the end of 6 weeks. But the insertion torque achieved was only 20 Ncm which indicated less primary stability. Hence, provisional acrylic restoration was avoided and it was decided to directly give a final PFM prosthesis at the end of 6 weeks. However, due to the clinical features of early implant failure at the end of 6 weeks, case was first treated by means of GBR and only at the end of 6 months follow up, PFM prosthesis was fabricated.

The early failing of implant presented here, may be due to early occlusal load on the implant (due to one-piece design) during the initial healing period or excessive surgical trauma, or lack of good initial stability due to unfavorable bone density at the implant site, or increased risk as the patient had a history of periodontitis.\[[@ref20][@ref21]\]

Treatment options for early failing implant include mechanical debridement, antimicrobial therapy, and GBR. A case report demonstrated successful management of an early failing implant through antimicrobial therapy and guided tissue regeneration.\[[@ref11]\] Similarly, in a recent case series, 18 implants undergoing early failure were treated successfully following the same protocol.\[[@ref9]\]

In the case presented here, successful treatment of failing implant was achieved, based on similar guidelines. The surgical treatment allowed complete access for the debridement of the peri-implant defect. Since the bone loss was severe, bone regenerative treatment like GBR using bioactive glass in combination with GTR membrane was attempted. Bioactive glass has been shown to regenerate bone around implants.\[[@ref15]\] Surface decontamination allowed for the removal of any residual infection not removed by debridement and made the implant surface conducive to bone regeneration and re-osseointegration.

CONCLUSION {#sec1-4}
==========

Surgical intervention with mechanical debridement, antimicrobial therapy, and guided bone regeneration may be carried out to salvage an early failing implant. Early detection with early intervention is important to control progressive bone loss around the implant and reverse the fate of implant. The technique mentioned here is not new. Literature is full of various techniques with variable outcomes. Future consideration should focus on proper case selection, avoidance of surgical failure, control of infection during surgery, and long-term follow ups with better study design.
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